tranScrip
Kate Dawson is a seasoned professional with extensive experience in business development, operations management, and client care. Currently serving as Senior Manager of BD Operations at tranScrip since December 2020, Kate previously held various roles in prestigious organizations, including Managing Director at Projectivity-online and Operations and Client Care Director at HewardMills. Additionally, Kate contributed as a member of the Public Advisory Group at the Royal College of Veterinary Surgeons in 2023. With a robust background in project coordination at GE Healthcare and earlier roles in finance and administration, Kate possesses a Bachelor of Science degree in Architecture from UCL.
This person is not in any offices
tranScrip
tranScrip is a leading contract drug development organisation which supports pharma and biotech companies in the development and lifecycle of medicines. We bring innovative solutions to clients’ global drug development needs. From translational medicine through to registration and post licencing, we deliver both strategic leadership and operational execution of development programmes, covering clinical, regulatory, drug safety, and commercial elements. Our teams of physicians, scientists and regulatory experts, help clients select the most promising drug candidates and bring them to the market. We guide our clients through their decision making from first in man studies to proof of concept and pivotal trials, regulatory submissions and product launches. In the last decade, tranScrip has supported over 250 clients and has been integral to many development programmes and regulatory submissions, bringing products to the market each year across a wide range of therapeutic areas.